Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -116,289 | -53,089 | -162,451 | -116,390 | -74,173 |
| Depreciation Amortization | 221 | 119 | 490 | 303 | 260 |
| Accounts payable and accrued liabilities | -7,586 | -5,681 | 4,598 | -1,175 | -3,566 |
| Other Working Capital | 3,027 | -2,193 | 2,775 | -1,362 | -5,780 |
| Other Operating Activity | 28,744 | 14,857 | 7,872 | 10,235 | 9,397 |
| Operating Cash Flow | $-91,883 | $-45,987 | $-146,716 | $-108,389 | $-73,862 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -221 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -118,179 | -69,941 | -500,722 | -247,370 | -175,718 |
| Sale Of Investment | 163,770 | 74,470 | 344,962 | 253,794 | 164,869 |
| Investing Cash Flow | $45,370 | $4,529 | $-155,760 | $6,424 | $-10,849 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 3,000 | 3,000 | 3,000 |
| Common Stock Issued | 46,811 | 50,348 | 214,811 | -5,255 | -5,296 |
| Other Financing Activity | 0 | -4,644 | -6,514 | 0 | 0 |
| Financing Cash Flow | $46,811 | $45,704 | $211,297 | $-2,255 | $-2,296 |
| Beginning Cash Position | 48,301 | 48,301 | 139,480 | 139,480 | 139,480 |
| End Cash Position | 48,599 | 52,547 | 48,301 | 35,260 | 52,473 |
| Net Cash Flow | $298 | $4,246 | $-91,179 | $-104,220 | $-87,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | -91,883 | -45,987 | -146,716 | -108,389 | -73,862 |
| Capital Expenditure | -221 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -92,104 | -45,987 | -146,716 | -108,389 | -73,862 |